SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-081867
Filing Date
2024-07-05
Accepted
2024-07-05 16:05:10
Documents
11
Period of Report
2024-07-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K igms-20240705.htm   iXBRL 8-K 45917
  Complete submission text file 0000950170-24-081867.txt   161687

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT igms-20240705.xsd EX-101.SCH 24818
13 EXTRACTED XBRL INSTANCE DOCUMENT igms-20240705_htm.xml XML 4709
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39045 | Film No.: 241102654
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)